Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact. The emergence …

This article provides a focused update to the clinical practice guideline on the treatment and
management of patients with coronavirus disease 2019, developed by the Infectious …

The coronavirus disease 2019 pandemic has underscored the importance of vaccines,
especially for immunocompromised populations like solid organ transplant recipients, who …

Abstract Although the mRNA SARS-CoV-2 vaccine has improved the mortality rate in the
general population, its efficacy against rapidly mutating virus strains, especially in kidney …

Background: Solid organ transplant (SOT) recipients are at risk of severe COVID-19.
Vaccination is an important preventive measure but may have side effects, including …

As solid organ transplant (SOT) recipients remain at risk of severe outcomes after SARS-
CoV-2 infections, vaccination continues to be an important preventive measure. In SOT …

Background Literature on the safety of remdesivir in hospitalized COVID-19 patients with
severe renal impairment is limited. We aimed to investigate the safety and effectiveness of …

Though antimicrobial stewardship programs (ASPs) are required for hospitals, the
involvement of transplant recipients in programmatic interventions, protocols, and metrics …

Introduction The incidence of mortality late in the pandemic, particularly after widespread
vaccine availability, is not well understood. Herein, we elucidate the effect of this impact of …

Background While coronavirus disease 2019 (COVID‐19) is no longer a public health
emergency, certain patients remain at risk of severe outcomes. To better understand …